Overview
Keita Sasa practices in Tokyo, Japan. Sasa is rated as an Advanced expert by MediFind in the treatment of Epithelioid Sarcoma. Their top areas of expertise are Epithelioid Sarcoma, Adult Soft Tissue Sarcoma, Inflammatory Myofibroblastic Tumor, and Osteosarcoma.
Their clinical research consists of co-authoring 18 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Epithelioid Sarcoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Epithelioid SarcomaSasa isAdvanced. Learn about Epithelioid Sarcoma.
- Experienced
- Adult Soft Tissue SarcomaSasa isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Bone TumorSasa isExperienced. Learn about Bone Tumor.
- FibrosarcomaSasa isExperienced. Learn about Fibrosarcoma.
- Gastrointestinal Stromal Tumor
- Inflammatory Myofibroblastic Tumor
- LiposarcomaSasa isExperienced. Learn about Liposarcoma.